Oppenheimer Upgrades Boston Scientific (BSX)

Boston Scientific Corporation
US ˙ NYSE ˙ US1011371077

Oppenheimer Upgrades Boston Scientific (BSX)

2025-09-08 17:09
US

Fintel reports that on September 8, 2025, Oppenheimer upgraded their outlook for Boston Scientific (NYSE:BSX) from Perform to Outperform.

Analyst Price Forecast Suggests 17.51% Upside

As of September 3, 2025, the average one-year price target for Boston Scientific is $125.99/share. The forecasts range from a low of $102.22 to a high of $147.00. The average price target represents an increase of 17.51% from its latest reported closing price of $107.22 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Boston Scientific is 14,925MM, a decrease of 19.30%. The projected annual non-GAAP EPS is 2.45.

What is the Fund Sentiment?

There are 2,895 funds or institutions reporting positions in Boston Scientific. This is an increase of 120 owner(s) or 4.32% in the last quarter. Average portfolio weight of all funds dedicated to BSX is 0.54%, an increase of 4.02%. Total shares owned by institutions increased in the last three months by 1.45% to 1,554,209K shares. BSX / Boston Scientific Corporation Put/Call Ratios The put/call ratio of BSX is 0.81, indicating a bullish outlook.

What are Other Shareholders Doing?

BSX / Boston Scientific Corporation Shares Held by Institutions

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 47,576K shares representing 3.21% ownership of the company. In its prior filing, the firm reported owning 46,630K shares , representing an increase of 1.99%. The firm decreased its portfolio allocation in BSX by 3.08% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 41,994K shares representing 2.83% ownership of the company. In its prior filing, the firm reported owning 40,952K shares , representing an increase of 2.48%. The firm decreased its portfolio allocation in BSX by 3.00% over the last quarter.

Primecap Management holds 34,663K shares representing 2.34% ownership of the company. In its prior filing, the firm reported owning 36,497K shares , representing a decrease of 5.29%. The firm decreased its portfolio allocation in BSX by 3.07% over the last quarter.

Bank Of America holds 33,845K shares representing 2.28% ownership of the company. In its prior filing, the firm reported owning 31,557K shares , representing an increase of 6.76%. The firm decreased its portfolio allocation in BSX by 74.27% over the last quarter.

Wellington Management Group Llp holds 32,649K shares representing 2.20% ownership of the company. In its prior filing, the firm reported owning 33,198K shares , representing a decrease of 1.68%. The firm decreased its portfolio allocation in BSX by 86.14% over the last quarter.

Other Listings
IT:1BSX 82,80 €
MX:BSX
DE:BSX 82,80 €
GB:0HOY 97,51 $
AT:BSXC
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista